UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of Earliest Event Reported): September 24, 2015

 

 

SIENTRA, INC.

(Exact Name of Registrant as Specified in Its Charter)

 

 

Delaware

 

001-36709

 

20-5551000

(State or Other Jurisdiction
of Incorporation)

 

(Commission
File Number)

 

(IRS Employer
Identification No.)

 

420 South Fairview Avenue, Suite 200

Santa Barbara, CA 93117

(Address of Principal Executive Offices and Zip Code)

 

(805) 562-3500

(Registrant’s Telephone Number, Including Area Code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o                 Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o                 Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o                 Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o                 Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


 

Item 8.01.                                        Other Events.

 

On September 24, 2015, Sientra, Inc. (the “Company”) issued a letter to its plastic surgeon customers regarding the suspension of the CE certificate for all medical devices made by Silimed, the Company’s contract manufacturer. A copy of the letter is filed as Exhibit 99.1 and is incorporated herein by reference.

 

Item 9.01.                                        Financial Statements and Exhibits.

 

(d)                                 Exhibits

 

Exhibit No.

 

Description

99.1

 

Letter from Sientra, Inc. to its plastic surgeon customers, dated September 24, 2015.

 

2


 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereto duly authorized.

 

 

SIENTRA, INC.

 

 

 

Dated: September 24, 2015

By:

/s/ Joel Smith

 

 

Joel Smith

 

 

General Counsel, Secretary and Chief Compliance Officer

 

3


 

INDEX TO EXHIBITS

 

Exhibit No.

 

Description

99.1

 

Letter from Sientra, Inc. to its plastic surgeon customers, dated September 24, 2015.

 

4